Cargando…
Metachronous Esophageal Ulcers after Immune-mediated Colitis Due to Immune Checkpoint Inhibitor Therapy: A Case Report and Literature Review
Although cases of gastrointestinal toxicity of pembrolizumab have been reported, cases of acute immune-mediated colitis accompanied with metachronous esophageal disorders (esophagitis and ulcer) are rare. We herein report a case of acute colitis and metachronous esophageal ulcers due to an immune-re...
Autores principales: | Ogawa, Soichiro, Kawakami, Hiroshi, Suzuki, Sho, Kuroki, Daisuke, Uchiyama, Naomi, Hatada, Hiroshi, Gi, Toshihiro, Sato, Yuichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479207/ https://www.ncbi.nlm.nih.gov/pubmed/33746162 http://dx.doi.org/10.2169/internalmedicine.6606-20 |
Ejemplares similares
-
Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary–pancreatic cancers
por: Ozono, Yoshinori, et al.
Publicado: (2023) -
Hematochezia Due to Panitumumab-induced Colitis with Vitamin K Deficiency
por: Tamura, Hotaka, et al.
Publicado: (2021) -
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
por: Middha, Pooja, et al.
Publicado: (2023) -
Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis
por: Ohwada, Sae, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitor-Induced Colitis Presenting As Lymphocytic Colitis
por: Khan, Jaffar, et al.
Publicado: (2021)